A Study of Doravirine and Islatravir as a Single Entity or Combination Therapy and the Effect of Food in Healthy Adult Participants (MK-8591A-055)
Clinical trial NCT06719570 · COMPLETED
Trial details
- NCT number
- NCT06719570
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-23
- Primary completion
- 2024-03-15
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.